Heterozygous carriers of the E161K mutation in the SCN5A gene, which encodes the Na V 1.5 pore-forming α-subunit of the ion channel carrying the cardiac fast sodium current (I Na We conclude that the E161K mutation underlies the clinically observed sinus node dysfunction. Furthermore, we conclude that the common H558R polymorphism does not significantly alter the effects of the E161K mutation.
Introduction

Aim of the study
The 'fast sodium current' (I Na ), which flows through Na V 1.5 sodium channels, is a key player in the electrical activity of the human heart [1] . The cardiac-specific Na V 1.5 protein, encoded by the SCN5A gene, is the poreforming α-subunit of the channel. Of note, a functional I Na channel is built with a single Na V 1.5 protein, in contrast with, for example, a functional 'pacemaker current' or 'funny current' (I f ) channel, which is a tetramer of four proteins from the HCN family, in particular HCN4 [2, 3] .
The large and fast influx of sodium ions through the Na V 1.5 channels is not only responsible for the fast upstroke of individual atrial and ventricular cardiomyocytes, but also for the fast impulse propagation in the atrial and ventricular tissue. Thus, I Na is an important determinant of the PQ interval, or PR interval, and the QRS duration on the body surface ECG. I Na has also been observed in human sinoatrial node cells [4] . Accordingly, it was included in the comprehensive computational model of a single human sinoatrial node (SAN) cell that was recently developed by Fabbri et al. [5] .
Mutations in genes encoding ion channel-related proteins may result in inherited arrhythmia disorders, in particular the long QT syndrome (LQTS) and the Brugada syndrome (BrS) [6] [7] [8] . LQTS shows an estimated prevalence of 1:2,000 [9] and is the most commonly encountered inherited arrhythmia disorder in clinical practice (≈35% [10] ). Estimates of the prevalence of BrS range from 1:5,000 to 1:2,000 [8] .
LQTS type 3 (LQT3) is caused by gain-of-function mutations in the SCN5A gene. Slowed or incomplete inactivation of the Na V 1.5 channel results in an additional inward current, known as late or persistent I Na , during the course of the ventricular action potential and thereby in an increase in action potential duration and prolongation of the QT interval on the ECG. The estimated prevalence of LQT3 among LQTS patients is ≈10% [11, 12] .
As far as a genetic basis for BrS is found, mutations in the SCN5A gene (BrS type 1, BrS1) are by far the most common, with a prevalence of up to 30% of all cases in which a genetic variant is implicated [8] . Mutations in SCN5A associated with BrS are all loss-of-function mutations, either caused by decreased expression of Na V 1.5 in the sarcolemma, expression of non-functional channels, or altered gating properties leading to a decreased I Na (e.g., delayed activation or earlier or faster inactivation) [7] . The mechanistic link between the BrS1 channelopathies and the associated changes in the ECG pattern are still a matter of debate [7, 8] .
Mutations in SCN5A may also lead to overlapping phenotypes (SCN5A overlap syndromes), where clinical characteristics of LQTS, BrS, and other arrhythmia syndromes (conduction disease, sinus node dysfunction) coexist in a single family or even in a single patient [6, 13] . Sinus node dysfunction (SND) is a relatively common observation in both LQTS3 and BrS1 patients [14, 15] .
In a recent study, we investigated the mechanisms of LQTS3-related SND at the cellular level with the use of the comprehensive computational model of a single human SAN cell of Fabbri et al. [5] , focusing on the 1795insD gain-of-function mutation in SCN5A [16] . In the present study, we assessed the cellular mechanism by which the E161K loss-of-function mutation in SCN5A causes BrS-related SND. Also, the potential role of the H558R polymorphism in SCN5A was investigated. This highly common polymorphism alters the effects of several mutations in SCN5A, including E161K, on sodium channel expression and/or kinetics [17] .
Data from literature
In 2005, Smits et al. [18] reported the biophysical features of a novel sodium channel mutation, E161K, which was identified in individuals of two non-related families with symptoms of sinus bradycardia, sinus node dysfunction, generalized conduction disease, and Brugada syndrome, or combinations thereof. E161K or wild-type sodium channel α-subunit was transfected into tsA201 cells together with wild-type β1-subunit. Voltage clamp experiments on the transfected cells revealed a 2.5-fold reduction in peak I Na at −20 mV for E161K sodium channels compared to wild-type channels. Furthermore, E161K sodium channels showed an 11.9 mV shift of the half-maximal activation potential (V 1/2 ) of the steady-state activation curve compared to wild-type (−30.7 ± 0.8 versus −42.6 ± 1.4 mV, respectively). Also, the steepness of this curve was slightly reduced; its slope factor amounted to 7.9 ± 0.3 versus 6.7 ± 0.4 mV, respectively. Voltage dependence of steady-state inactivation, recovery from inactivation, and development of slow inactivation were not found to be affected by the E161K mutation. Of note, these data were obtained in H558 background.
More recently, Gui et al. [17, 19] carried out voltage experiments on HEK-293 cells transfected with E161K mutant or wild-type sodium channel α-subunit. Like Smits et al. [18] , they observed a reduction in peak I Na for E161K sodium channels compared to wild-type channels, both in H558 and R558 background. In either case, this reduction was approximately 4-fold, which is more pronounced than the 2.5-fold reduction in the study by Smits et al. [18] . With a value of ≈19 mV, in H558 background, the positive shift in V 1/2 of the steady-state activation curve was also more pronounced. The slope factor of this curve showed an increase similar to that observed by Smits et al. [18] .
In R558 background, the reduction in peak I Na and steepness of the steady-state activation curve were both similar to those in H558 background [17] . However, the positive shift in V 1/2 of the steady-state activation curve was less pronounced, with a value of ≈13 mV rather than ≈19 mV. Furthermore, the steady-state inactivation curve showed a shift of −10 mV in R558 background, whereas such change was absent in H558 background.
Methods
Effects of the heterozygous E161K mutation in SCN5A were implemented in the CellML code [20] of the FabbriSeveri human SAN cell model [5] by scaling the fullyactivated conductance of I Na and shifting the voltage dependence of I Na activation and/or inactivation, based on the data from literature described in Section 1.2. The slight change in the steepness of the steady-state activation curve was ignored. These modifications were applied to half of the intrinsic I Na channels, thus representing the heterozygous nature of the mutation. Similar changes were applied to the CourtemancheRamirez-Nattel human right atrial cell model [21] .
In H558 background, the voltage dependence of I Na activation was shifted by +19 mV. In R558 background, the voltage dependence of I Na activation was shifted by +13 mV, together with a −10 mV shift in voltage dependence of inactivation. In either background, a 50% decrease in fully-activated conductance was applied to arrive at a 4-fold decrease in peak current density of I Na during voltage clamp simulations.
The default Fabbri-Severi model has a beating rate of 74 beats/min. This rate was lowered to 49 beats/min through the simulated administration of 20 nM acetylcholine (ACh; vagal tone) [5] . Simulations of the E161K mutation were carried out both under control conditions (i.e., normal autonomic tone) and under vagal tone.
The CellML code was edited and run in the Cellular Open Resource (COR) environment [22] , version 0.9.31.1409. The Courtemanche-Ramirez-Nattel model was coded using Intel Visual Fortran and run on an Intel Core i7 based workstation as a 32-bit Windows application, applying a simple and efficient Euler-type integration scheme with a 1-μs time step. All simulations were run for a sufficiently long time to reach steady-state behavior.
Results
We started our simulations with the default SAN cell model (i.e., normal autonomic tone). As shown in Fig. 1 , the current through the E161K mutant channels is effectively zero, both in H558 and R558 background. As a result, diastolic depolarization rate decreases and cycle length increases from 813.4 to 867.8 ms. This 54-ms increase in cycle length corresponds with a moderate 6.3% decrease in beating rate from 74 to 69 beats/min. Figure 1 . Effect of the heterozygous E161K mutation in SCN5A on the electrical activity of the Fabbri et al. [5] human SAN cell model at normal beating rate (normal autonomic tone), both in H558 and R558 background. Membrane potential (V m ), net membrane current (I net ), fast sodium current through wild-type channels (I Na,WT ) and remaining wildtype or mutant channels (I Na,mut ). Figure 2 . Effect of the heterozygous E161K mutation in SCN5A on the electrical activity of the Fabbri et al. [5] human SAN cell model at low beating rate (vagal tone; 20 nM ACh), both in H558 and R558 background. Membrane potential (V m ), net membrane current (I net ), fast sodium current through wild-type channels (I Na,WT ) and remaining wild-type or mutant channels (I Na,mut ).
We repeated our simulations under vagal tone (20 nM ACh). Vagal tone per se increases cycle length from 813.4 to 1231.3 ms (+51%), which is largely established through a decrease in net membrane current (I net ) and associated diastolic depolarization rate. The effect of the E161K mutation is now considerably larger, with a 191-ms increase in cycle length to 1422.6 ms (Fig. 2) , corresponding with a 13% decrease in beating rate from 49 to 42 beats/min, in line with the clinical observations by Smits et al. [18] .
The E161K mutation does not only increase the intrinsic cycle length of the SAN cells. It also reduces atrial excitability, as demonstrated by the ≈2.2-fold increase in threshold stimulus current of the simulated right atrial cell, virtually independent of the H558 or R558 background (data not shown), adding to the clinically observed sinus bradycardia and sinus node dysfunction.
Conclusion
We conclude that the experimentally identified mutationinduced changes in I Na can explain the clinically observed sinus node dysfunction. Furthermore, we conclude that the common H558R polymorphism does not significantly alter the effects of the E161K mutation.
